Sana Biotechnology, Inc. Common Stock

SANANASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
2.36 USD
↗ 0.03 (1.29%)AT CLOSE (03:59 PM EDT)
2.34
↘ 0.02 (1.02%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.34
↘ 0.02 (1.02%)
🔴Market: CLOSED

Shares of Sana Biotechnology, Inc. Common Stock (SANA) are trading at $2.36. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, SANA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 26, 2026.

Open?$2.33
High?$2.39
Low?$2.29
Prev. Close?$2.33
Volume?1.5M
Avg. Volume?3.7M
VWAP?$2.35
Rel. Volume?0.41x
Bid / Ask
Bid?$2.29 × 700
Ask?$2.39 × 700
Spread?$0.10
Midpoint?$2.34
Valuation & Ratios
Market Cap?697.5M
Shares Out?299.4M
Float?184.1M
Float %?61.5%
P/E Ratio?N/A
P/B Ratio?4.51
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingHealthcare - Oncology›Cell & Gene Therapy for Cancer
Employees
142
Market Cap
697.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.sana.com
Listed
2021-02-04
Address
188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
Phone: (206) 701-7914
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
14
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.39Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?22.18%Squeeze Risk
Short Interest?40.8M
Days to Cover?11.0
Free Float184.1M
Avg Daily Volume3.7M
Settlement Date2026-10-15
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?1.38Adequate
Cash Ratio?0.46Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
40
4.51FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-137.0%WEAK▾
ROA?
S&P
3
-49.1%WEAK▾
Cash Flow & Enterprise
FCF?$-135062000
Enterprise Value?$640.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist